BNR
Income statement / Annual
Last year (2023), Burning Rock Biotech Limited's total revenue was $537.44 M,
a decrease of 4.58% from the previous year.
In 2023, Burning Rock Biotech Limited's net income was -$653.69 M.
See Burning Rock Biotech Limited’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$537.44 M
|
$563.24 M
|
$507.86 M
|
$429.90 M
|
$381.68 M
|
$208.87 M
|
$111.17 M
|
| Cost of Revenue |
$174.21 M |
$183.20 M |
$143.72 M |
$115.98 M |
$108.34 M |
$73.81 M |
$39.47 M |
| Gross Profit |
$363.23 M |
$380.04 M |
$364.15 M |
$313.92 M |
$273.33 M |
$135.06 M |
$71.70 M |
| Gross Profit Ratio |
0.68 |
0.67 |
0.72 |
0.73 |
0.72 |
0.65 |
0.64 |
| Research and Development
Expenses |
$347.02 M
|
$421.87 M
|
$367.86 M
|
$263.94 M
|
$156.94 M
|
$105.30 M
|
$49.02 M
|
| General & Administrative
Expenses |
$437.82 M
|
$568.28 M
|
$490.26 M
|
$293.80 M
|
$132.16 M
|
$88.30 M
|
$76.04 M
|
| Selling & Marketing
Expenses |
$247.71 M
|
$370.29 M
|
$303.10 M
|
$168.59 M
|
$153.33 M
|
$102.86 M
|
$67.51 M
|
| Selling, General &
Administrative Expenses |
$685.53 M
|
$938.58 M
|
$793.35 M
|
$462.39 M
|
$285.49 M
|
$191.16 M
|
$143.54 M
|
| Other Expenses |
$0.00 |
$152,000.00 |
$199,000.00 |
-$887,000.00 |
-$883,000.00 |
-$488,000.00 |
-$32,000.00 |
| Operating Expenses |
$1.03 B |
$1.36 B |
$1.16 B |
$726.33 M |
$442.43 M |
$296.46 M |
$192.56 M |
| Cost And Expenses |
$1.21 B |
$1.54 B |
$1.30 B |
$842.31 M |
$550.77 M |
$370.26 M |
$232.03 M |
| Interest Income |
$17.96 M |
$9.46 M |
$3.46 M |
$6.07 M |
$2.17 M |
$1.34 M |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$1.54 M |
$667,000.00 |
$8.99 M |
$17.95 M |
$0.00 |
| Depreciation &
Amortization |
$133.40 M
|
$124.10 M
|
$47.77 M
|
$33.31 M
|
$31.36 M
|
$24.68 M
|
$21.31 M
|
| EBITDA |
-$517.90 M
|
-$856.31 M
|
-$746.50 M
|
-$373.26 M
|
-$136.38 M
|
-$135.87 M
|
-$99.55 M
|
| EBITDA Ratio |
-0.96 |
-1.74 |
-1.56 |
-0.95 |
-0.36 |
-0.65 |
-0.89 |
| Operating Income Ratio
|
-1.25
|
-1.74
|
-1.57
|
-0.96
|
-0.44
|
-0.77
|
-1.09
|
| Total Other
Income/Expenses Net |
$18.02 M
|
$11.16 M
|
$1.27 M
|
$5.17 M
|
-$64,000.00
|
-$16.10 M
|
-$10.41 M
|
| Income Before Tax |
-$651.30 M |
-$969.25 M |
-$795.80 M |
-$407.24 M |
-$169.16 M |
-$177.50 M |
-$131.28 M |
| Income Before Tax Ratio
|
-1.21
|
-1.72
|
-1.57
|
-0.95
|
-0.44
|
-0.85
|
-1.18
|
| Income Tax Expense |
$2.39 M |
$1.99 M |
$899,000.00 |
-$33.53 M |
-$819,000.00 |
$1.85 M |
$10.38 M |
| Net Income |
-$653.69 M |
-$971.23 M |
-$796.70 M |
-$373.71 M |
-$168.34 M |
-$177.50 M |
-$131.28 M |
| Net Income Ratio |
-1.22 |
-1.72 |
-1.57 |
-0.87 |
-0.44 |
-0.85 |
-1.18 |
| EPS |
-63.84 |
-9.35 |
-7.65 |
-5.44 |
-1.94 |
-7.93 |
-1.6 |
| EPS Diluted |
-63.84 |
-9.35 |
-7.65 |
-5.44 |
-1.94 |
-7.93 |
-1.6 |
| Weighted Average Shares
Out |
$10.24 M
|
$103.91 M
|
$104.21 M
|
$68.63 M
|
$86.82 M
|
$22.38 M
|
$82.08 M
|
| Weighted Average Shares
Out Diluted |
$10.24 M
|
$103.91 M
|
$104.21 M
|
$68.63 M
|
$86.82 M
|
$22.38 M
|
$82.08 M
|
| Link |
|
|
|
|
|
|
|
